MedTrace Logo

Chest Dysphoria in Transmasculine Spectrum Adolescents

NCT04195659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2022-06-10

No results posted yet for this study

Summary

The investigators hypothesize that masculinizing top surgery (e.g., mastectomy and chest masculinization) leads to an improvement in self-report chest dysphoria, gender dysphoria, and gender congruence in assigned-female-at-birth, transgender and non-binary youth and young adults. This is a prospective, observational study that will enroll assigned-female-at-birth, transmasculine spectrum individuals age 13 to 25 years old who are or are not undergoing top surgery. Participants will complete a set of standard of care questionnaires regarding their chest dysphoria (e.g., distress about the chest), gender dysphoria (e.g., distress about a gender identity that does not match assigned sex), and gender congruence (e.g., degree to which an individual feels they are living in their authentic appearance and gender identity). They will complete this same set of questionnaires either three months after their top surgery or three months after the initial set of surveys.

Conditions

  • Gender Dysphoria

Interventions

PROCEDURE

Mastectomy and chest masculinization

A surgical procedure in which the breasts are removed and the chest is given a masculine contour.

Sponsors & Collaborators

  • Ann and Robert H. Lurie Children's Hospital of Chicago

    collaborator UNKNOWN

  • University of Illinois at Chicago

    collaborator OTHER

  • Northwestern University

    lead OTHER

Principal Investigators

  • Sumanas W Jordan, MD PhD · Northwestern University

Eligibility

Min Age
13 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-29
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04195659 on ClinicalTrials.gov